PALLIATIVE CARE:@0.084848:0.038601:0.271324:0.038601:0.271324:0.019343:0.084848:0.019343:0.012173:0.017404:0.010866:0.010866:0.005315:0.015482:0.010019:0.005315:0.016510:0.012606:0.006515:0.019121:0.017404:0.014276:0.012606
168:@0.018436:0.038809:0.050045:0.038809:0.050045:0.019212:0.018436:0.019212:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
literature. :@0.121195:0.094740:0.203650:0.094740:0.203650:0.080735:0.121195:0.080735:0.003421:0.003421:0.005798:0.011118:0.005148:0.011682:0.005798:0.010399:0.005075:0.011118:0.004738:0.004738
J  Pain  Symptom  Management.:@0.207469:0.094740:0.475775:0.094740:0.475775:0.080735:0.207469:0.080735:0.008244:0.004738:0.003821:0.010126:0.011682:0.003421:0.010434:0.004738:0.003823:0.008518:0.009168:0.016044:0.011665:0.005798:0.011203:0.016044:0.004738:0.003823:0.015719:0.011682:0.010434:0.011682:0.011511:0.011118:0.016044:0.011118:0.010434:0.005798:0.004738
 :@0.475751:0.094740:0.480489:0.094740:0.480489:0.080735:0.475751:0.080735:0.004738
2002;24(5):526-42.:@0.121195:0.108310:0.267420:0.108310:0.267420:0.094305:0.121195:0.094305:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
8. :@0.084848:0.121880:0.103800:0.121880:0.103800:0.107875:0.084848:0.107875:0.009476:0.004738:0.004738
 Van den Beuken-van Everdingen MHJ, de :@0.121195:0.121880:0.480496:0.121880:0.480496:0.107875:0.121195:0.107875:0.000000:0.010230:0.011682:0.010434:0.006712:0.011716:0.011118:0.010434:0.006708:0.009818:0.011118:0.010399:0.008586:0.011118:0.010434:0.005679:0.009476:0.011682:0.010434:0.006708:0.009168:0.009476:0.011118:0.005049:0.011716:0.003421:0.010434:0.011511:0.011118:0.010434:0.006707:0.015719:0.011682:0.008244:0.004738:0.006708:0.011716:0.011118:0.004738
Rijke JM, Kessels AG,:@0.121195:0.135450:0.297541:0.135450:0.297541:0.121445:0.121195:0.121445:0.010382:0.003421:0.003472:0.008586:0.011118:0.007560:0.008244:0.015719:0.004738:0.007560:0.010109:0.011118:0.006636:0.006636:0.011118:0.003421:0.006636:0.007560:0.012657:0.014915:0.004738
 et al.:@0.297541:0.135450:0.349419:0.135450:0.349419:0.121445:0.297541:0.121445:0.007560:0.011118:0.005798:0.007560:0.011682:0.003421:0.004738
 Prevalence of :@0.349419:0.135450:0.480484:0.135450:0.480484:0.121445:0.349419:0.121445:0.007560:0.010126:0.005075:0.011118:0.009476:0.011682:0.003421:0.011118:0.010434:0.011067:0.011118:0.007560:0.011203:0.005371:0.004738
pain in patients with cancer: a systematic :@0.121195:0.149021:0.480494:0.149021:0.480494:0.135015:0.121195:0.135015:0.011665:0.011682:0.003421:0.010434:0.006465:0.003421:0.010434:0.006465:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.006465:0.014214:0.003421:0.005798:0.010434:0.006465:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.006453:0.011682:0.006465:0.006636:0.009168:0.006636:0.005798:0.011118:0.016044:0.011682:0.005798:0.003421:0.011067:0.004738
review of  the  past 40 years. :@0.121195:0.162591:0.373064:0.162591:0.373064:0.148585:0.121195:0.148585:0.005078:0.011118:0.009476:0.003421:0.011118:0.014214:0.009117:0.011203:0.005371:0.004738:0.004368:0.005798:0.010434:0.011118:0.004738:0.004363:0.011665:0.011682:0.006636:0.005798:0.009117:0.009476:0.009476:0.009117:0.009168:0.011118:0.011682:0.005148:0.006636:0.004738:0.004738
Ann  Oncol:@0.377418:0.162591:0.471036:0.162591:0.471036:0.148585:0.377418:0.148585:0.012657:0.010434:0.010434:0.004738:0.004367:0.014864:0.010434:0.011067:0.011203:0.003421
. :@0.471036:0.162591:0.480512:0.162591:0.480512:0.148585:0.471036:0.148585:0.004738:0.004738
2007;18(9):1437-1449.:@0.121195:0.176161:0.295848:0.176161:0.295848:0.162156:0.121195:0.162156:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
9. :@0.084848:0.189731:0.103800:0.189731:0.103800:0.175726:0.084848:0.175726:0.009476:0.004738:0.004738
 Zylla D, Kuskowski MA, Gupta K, :@0.121195:0.189731:0.386154:0.189731:0.386154:0.175726:0.121195:0.175726:0.000000:0.008210:0.009168:0.003421:0.003421:0.011682:0.004938:0.012726:0.004738:0.004926:0.010109:0.010399:0.006636:0.008586:0.011203:0.014214:0.006636:0.008586:0.003421:0.004926:0.015719:0.012657:0.004738:0.004926:0.014915:0.010399:0.011665:0.005798:0.011682:0.004926:0.010109:0.004738:0.004738
et al:@0.386342:0.189731:0.423287:0.189731:0.423287:0.175726:0.386342:0.175726:0.011118:0.005798:0.004926:0.011682:0.003421
. Asso-:@0.423287:0.189731:0.475763:0.189731:0.475763:0.175726:0.423287:0.175726:0.004738:0.004926:0.012657:0.006636:0.006636:0.011203:0.005679
ciation of opioid requirement and cancer :@0.121195:0.203301:0.480525:0.203301:0.480525:0.189296:0.121195:0.189296:0.011067:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.006551:0.011203:0.005371:0.006551:0.011203:0.011665:0.003421:0.011203:0.003421:0.011716:0.006551:0.005078:0.011118:0.011665:0.010399:0.003421:0.005080:0.011118:0.016044:0.011118:0.010434:0.005798:0.006537:0.011682:0.010434:0.011716:0.006551:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738
pain with  survival in  advanced non-small :@0.121195:0.216871:0.480503:0.216871:0.480503:0.202866:0.121195:0.202866:0.011665:0.011682:0.003421:0.010434:0.008432:0.014214:0.003421:0.005798:0.010434:0.004738:0.003684:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011682:0.003421:0.008432:0.003421:0.010434:0.004738:0.003684:0.011682:0.011716:0.009476:0.011682:0.010434:0.011067:0.011118:0.011716:0.008432:0.010434:0.011203:0.010434:0.005679:0.006636:0.016044:0.011682:0.003421:0.003421:0.004738
cell lung cancer. :@0.121195:0.230442:0.274460:0.230442:0.274460:0.216436:0.121195:0.216436:0.011067:0.011118:0.003421:0.003421:0.009869:0.003421:0.010399:0.010434:0.011511:0.009869:0.011067:0.011682:0.010434:0.011067:0.011118:0.003893:0.004738:0.004738
Br J Anaesth:@0.279592:0.230442:0.391300:0.230442:0.391300:0.216436:0.279592:0.216436:0.009818:0.005148:0.009869:0.008244:0.009869:0.012657:0.010434:0.011682:0.011118:0.006636:0.005798:0.010434
. 2014  Jul :@0.391300:0.230442:0.480498:0.230442:0.480498:0.216436:0.391300:0.216436:0.004738:0.009869:0.009476:0.009476:0.009476:0.009476:0.004738:0.005147:0.008244:0.010399:0.003421:0.004738
1;113(Suppl 1):i109-i116.:@0.121195:0.244012:0.315193:0.244012:0.315193:0.230007:0.121195:0.230007:0.009476:0.004738:0.009476:0.009476:0.009476:0.006312:0.008518:0.010399:0.011665:0.011665:0.003421:0.004738:0.009476:0.006312:0.004738:0.003421:0.009476:0.009476:0.009476:0.005679:0.003421:0.009476:0.009476:0.009476:0.004738
10.   Zaza  C,  Baine N.  Cancer  pain and  psy-:@0.084848:0.257582:0.475756:0.257582:0.475756:0.243577:0.084848:0.243577:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.008210:0.011682:0.007269:0.011682:0.004738:0.004642:0.013906:0.004738:0.004738:0.004640:0.009818:0.011682:0.003421:0.010434:0.011118:0.009390:0.012657:0.004738:0.004738:0.004635:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.004637:0.011665:0.011682:0.003421:0.010434:0.009390:0.011682:0.010434:0.011716:0.004738:0.004644:0.011665:0.006636:0.009168:0.005679
chosocial factors:  a critical review of :@0.121195:0.271152:0.480493:0.271152:0.480493:0.257147:0.121195:0.257147:0.011067:0.010434:0.011203:0.006636:0.011203:0.011067:0.003421:0.011682:0.003421:0.015018:0.005371:0.011682:0.011067:0.005798:0.011203:0.005148:0.006636:0.004738:0.004738:0.010269:0.011682:0.015018:0.011067:0.005148:0.003421:0.005798:0.003421:0.011067:0.011682:0.003421:0.015018:0.005077:0.011118:0.009476:0.003421:0.011118:0.014214:0.015018:0.011203:0.005371:0.004738
the literature. :@0.121195:0.284722:0.241057:0.284722:0.241057:0.270717:0.121195:0.270717:0.005798:0.010434:0.011118:0.010057:0.003421:0.003421:0.005798:0.011118:0.005148:0.011682:0.005798:0.010399:0.005075:0.011118:0.004738:0.004738
J Pain Symptom Manage:@0.246377:0.284722:0.471043:0.284722:0.471043:0.270717:0.246377:0.270717:0.008244:0.010057:0.010126:0.011682:0.003421:0.010434:0.010057:0.008518:0.009168:0.016044:0.011665:0.005798:0.011203:0.016044:0.010057:0.015719:0.011682:0.010434:0.011682:0.011511:0.011118
. :@0.471043:0.284722:0.480518:0.284722:0.480518:0.270717:0.471043:0.270717:0.004738:0.004738
2002;24(5):526-542.:@0.121195:0.298293:0.276896:0.298293:0.276896:0.284287:0.121195:0.284287:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
11.   National Comprehensive Cancer Network. :@0.084848:0.311863:0.480513:0.311863:0.480513:0.297857:0.084848:0.297857:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.012657:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.005272:0.013906:0.011203:0.016044:0.011665:0.005077:0.011118:0.010434:0.011118:0.010434:0.006636:0.003421:0.009476:0.011118:0.005275:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.005268:0.012657:0.011118:0.005798:0.014214:0.011203:0.005148:0.008586:0.004738:0.004738
NCCN Guidelines. :@0.121195:0.325433:0.274330:0.325433:0.274330:0.311428:0.121195:0.311428:0.012657:0.013906:0.013906:0.012657:0.003934:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.004738:0.004738
Adult Cancer Pain:@0.273544:0.325433:0.424428:0.325433:0.424428:0.311428:0.273544:0.311428:0.012657:0.011716:0.010399:0.003421:0.005798:0.003939:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.003936:0.010126:0.011682:0.003421:0.010434
; 2017.:@0.424428:0.325433:0.475748:0.325433:0.475748:0.311428:0.424428:0.311428:0.004738:0.003941:0.009476:0.009476:0.009476:0.009476:0.004738
12.   World Health Organization. :@0.084848:0.339003:0.360160:0.339003:0.360160:0.324998:0.084848:0.324998:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015635:0.011203:0.005148:0.003421:0.011716:0.010673:0.011682:0.011118:0.011682:0.003421:0.005798:0.010434:0.010673:0.014864:0.005164:0.011511:0.011682:0.010434:0.003421:0.007269:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738
Cancer  Pain :@0.366078:0.339003:0.480498:0.339003:0.480498:0.324998:0.366078:0.324998:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.005927:0.010126:0.011682:0.003421:0.010434:0.004738
Relief:@0.121195:0.352573:0.166026:0.352573:0.166026:0.338568:0.121195:0.338568:0.010382:0.011118:0.003421:0.003421:0.011118:0.005371
. Geneva: World Health Organization; :@0.166026:0.352573:0.480506:0.352573:0.480506:0.338568:0.166026:0.338568:0.004738:0.004659:0.014915:0.011118:0.010434:0.011118:0.009476:0.011682:0.004738:0.004658:0.015635:0.011203:0.005148:0.003421:0.011716:0.004658:0.011682:0.011118:0.011682:0.003421:0.005798:0.010434:0.004669:0.014864:0.005164:0.011511:0.011682:0.010434:0.003421:0.007269:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738
1986.:@0.121195:0.366143:0.163836:0.366143:0.163836:0.352138:0.121195:0.352138:0.009476:0.009476:0.009476:0.009476:0.004738
13.   World Health Organization. :@0.084848:0.379714:0.360160:0.379714:0.360160:0.365708:0.084848:0.365708:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015635:0.011203:0.005148:0.003421:0.011716:0.010673:0.011682:0.011118:0.011682:0.003421:0.005798:0.010434:0.010673:0.014864:0.005164:0.011511:0.011682:0.010434:0.003421:0.007269:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738
Cancer  Pain :@0.366078:0.379714:0.480498:0.379714:0.480498:0.365708:0.366078:0.365708:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.005927:0.010126:0.011682:0.003421:0.010434:0.004738
Relief. :@0.121195:0.393284:0.175501:0.393284:0.175501:0.379279:0.121195:0.379279:0.010382:0.011118:0.003421:0.003421:0.011118:0.005371:0.004738:0.004738
2nd ed. Geneva: World Health Or-:@0.178324:0.393284:0.475753:0.393284:0.475753:0.379279:0.178324:0.379279:0.009476:0.010434:0.011716:0.007560:0.011118:0.011716:0.004738:0.007560:0.014915:0.011118:0.010434:0.011118:0.009476:0.011682:0.004738:0.007560:0.015635:0.011203:0.005148:0.003421:0.011716:0.007560:0.011682:0.011118:0.011682:0.003421:0.005798:0.010434:0.007560:0.014864:0.005148:0.005679
ganization; 1996.:@0.121195:0.406854:0.260168:0.406854:0.260168:0.392849:0.121195:0.392849:0.011511:0.011682:0.010434:0.003421:0.007269:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738
14.   Wallenstein S, Heidrich Gr, Kaiko R. Clinical :@0.084848:0.420424:0.480474:0.420424:0.480474:0.406419:0.084848:0.406419:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015568:0.011682:0.003421:0.003421:0.011118:0.010434:0.006636:0.005798:0.011118:0.003421:0.010434:0.006055:0.008518:0.004738:0.006055:0.011682:0.011118:0.003421:0.011716:0.005148:0.003421:0.011067:0.010434:0.006055:0.014915:0.003351:0.004738:0.006055:0.010109:0.011682:0.003421:0.008586:0.011203:0.006055:0.010382:0.004738:0.006055:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.004738
evaluation of mild  analgesics:  the meas-:@0.121195:0.433994:0.475755:0.433994:0.475755:0.419989:0.121195:0.419989:0.011118:0.009476:0.011682:0.003421:0.010399:0.011682:0.005798:0.003421:0.011203:0.010434:0.008775:0.011203:0.005371:0.008775:0.016044:0.003421:0.003421:0.011716:0.004738:0.004047:0.011682:0.010434:0.011682:0.003421:0.011511:0.011118:0.006636:0.003421:0.011067:0.006636:0.004738:0.004738:0.004047:0.005798:0.010434:0.011118:0.008775:0.016044:0.011118:0.011682:0.006636:0.005679
urement of clinical pain. :@0.121195:0.447565:0.330765:0.447565:0.330765:0.433559:0.121195:0.433559:0.010399:0.005077:0.011118:0.016044:0.011118:0.010434:0.005798:0.006127:0.011203:0.005371:0.006130:0.011067:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.006140:0.011665:0.011682:0.003421:0.010434:0.004738:0.004738
Br J Clin Pharma-:@0.332167:0.447565:0.475775:0.447565:0.475775:0.433559:0.332167:0.433559:0.009818:0.005148:0.006140:0.008244:0.006140:0.013906:0.003421:0.003421:0.010434:0.006140:0.010126:0.010434:0.011682:0.005148:0.016044:0.011682:0.005679
col:@0.121195:0.461135:0.146886:0.461135:0.146886:0.447129:0.121195:0.447129:0.011067:0.011203:0.003421
. 1980;10(Suppl 2):319S-327S.:@0.146886:0.461135:0.379505:0.461135:0.379505:0.447129:0.146886:0.447129:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.008518:0.010399:0.011665:0.011665:0.003421:0.004738:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.008518:0.005679:0.009476:0.009476:0.009476:0.008518:0.004738
15.   Littman G, Walker B, Schneider B. Reas-:@0.084848:0.474705:0.475787:0.474705:0.475787:0.460700:0.084848:0.460700:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.007902:0.003421:0.005798:0.005798:0.016044:0.011682:0.010434:0.010126:0.014915:0.004738:0.010126:0.015567:0.011682:0.003421:0.008586:0.011118:0.005148:0.010126:0.009818:0.004738:0.010126:0.008518:0.011067:0.010434:0.010434:0.011118:0.003421:0.011716:0.011118:0.005148:0.010126:0.009818:0.004738:0.010126:0.010382:0.011118:0.011682:0.006636:0.005679
sessment of verbal and visual  analog rat-:@0.121195:0.488275:0.475750:0.488275:0.475750:0.474270:0.121195:0.474270:0.006636:0.011118:0.006636:0.006636:0.016044:0.011118:0.010434:0.005798:0.007321:0.011203:0.005371:0.007321:0.009476:0.011118:0.005148:0.011665:0.011682:0.003421:0.007321:0.011682:0.010434:0.011716:0.007321:0.009476:0.003421:0.006636:0.010399:0.011682:0.003421:0.004738:0.002598:0.011682:0.010434:0.011682:0.003421:0.011203:0.011511:0.007321:0.005148:0.011682:0.005798:0.005679
ings  in  analgesic studies. :@0.121195:0.501845:0.340403:0.501845:0.340403:0.487840:0.121195:0.487840:0.003421:0.010434:0.011511:0.006636:0.004738:0.004317:0.003421:0.010434:0.004738:0.004319:0.011682:0.010434:0.011682:0.003421:0.011511:0.011118:0.006636:0.003421:0.011067:0.009065:0.006636:0.005798:0.010399:0.011716:0.003421:0.011118:0.006636:0.004738:0.004738
Clin Pharmacol :@0.344715:0.501845:0.480506:0.501845:0.480506:0.487840:0.344715:0.487840:0.013906:0.003421:0.003421:0.010434:0.009065:0.010126:0.010434:0.011682:0.005148:0.016044:0.011682:0.011067:0.011203:0.003421:0.004738
Ther:@0.121195:0.515416:0.155181:0.515416:0.155181:0.501410:0.121195:0.501410:0.007286:0.010434:0.011118:0.005148
.1985;38(1):16-23.:@0.155164:0.515416:0.296652:0.515416:0.296652:0.501410:0.155164:0.501410:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
16.   Serlin RC, Mendoza TR, Nakamura Y. When :@0.084848:0.528986:0.480512:0.528986:0.480512:0.514980:0.084848:0.514980:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.008518:0.011118:0.005148:0.003421:0.003421:0.010434:0.005319:0.010382:0.013906:0.004738:0.005319:0.015719:0.011118:0.010434:0.011716:0.011203:0.007269:0.011682:0.005311:0.007286:0.010382:0.004738:0.005319:0.012657:0.011682:0.008586:0.011682:0.016044:0.010399:0.005148:0.011682:0.005319:0.009011:0.004738:0.005319:0.016420:0.010434:0.011118:0.010434:0.004738
is cancer pain mild, moderate or severe? :@0.121195:0.542556:0.480515:0.542556:0.480515:0.528551:0.121195:0.528551:0.003421:0.006636:0.007115:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.007095:0.011665:0.011682:0.003421:0.010434:0.007115:0.016044:0.003421:0.003421:0.011716:0.004738:0.007115:0.016044:0.011203:0.011716:0.011118:0.005148:0.011682:0.005798:0.011118:0.007093:0.011203:0.005148:0.007097:0.006636:0.011118:0.009476:0.011118:0.005082:0.011118:0.010109:0.004738
Grading  pain severity  by  its interference :@0.121195:0.556126:0.480517:0.556126:0.480517:0.542121:0.121195:0.542121:0.014915:0.005148:0.011682:0.011716:0.003421:0.010434:0.011511:0.004738:0.004844:0.011665:0.011682:0.003421:0.010434:0.009596:0.006636:0.011118:0.009476:0.011118:0.005148:0.003421:0.005798:0.009168:0.004738:0.004849:0.011665:0.009168:0.004738:0.004849:0.003421:0.005798:0.006636:0.009596:0.003421:0.010434:0.005798:0.011118:0.005964:0.005371:0.011118:0.005075:0.011118:0.010434:0.011067:0.011118:0.004738
with function. :@0.121195:0.569696:0.237402:0.569696:0.237402:0.555691:0.121195:0.555691:0.014214:0.003421:0.005798:0.010434:0.004738:0.005371:0.010399:0.010434:0.011067:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738
Pain. :@0.237385:0.569696:0.282523:0.569696:0.282523:0.555691:0.237385:0.555691:0.010126:0.011682:0.003421:0.010434:0.004738:0.004738
1995;61:277-284.:@0.282523:0.569696:0.416126:0.569696:0.416126:0.555691:0.282523:0.555691:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
17.   Lussier D, Portenoy RK. Adjuvant analgesic :@0.084848:0.583266:0.480496:0.583266:0.480496:0.569261:0.084848:0.569261:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.007902:0.010399:0.006636:0.006636:0.003421:0.011118:0.005148:0.005969:0.012726:0.004738:0.005969:0.010126:0.011203:0.005148:0.005798:0.011118:0.010434:0.011203:0.009168:0.005944:0.010382:0.010109:0.004738:0.005959:0.012657:0.011716:0.003472:0.010399:0.009476:0.011682:0.010434:0.005798:0.005961:0.011682:0.010434:0.011682:0.003421:0.011511:0.011118:0.006636:0.003421:0.011067:0.004738
drugs. In Bruera E, Higginson IJ,Ripamonti C, :@0.121195:0.596837:0.480489:0.596837:0.480489:0.582831:0.121195:0.582831:0.011716:0.005148:0.010399:0.011511:0.006636:0.004738:0.003848:0.003866:0.010434:0.003848:0.009818:0.005148:0.010399:0.011118:0.005148:0.011682:0.003848:0.009168:0.004738:0.003848:0.011682:0.003421:0.011511:0.011511:0.003421:0.010434:0.006636:0.011203:0.010434:0.003848:0.003866:0.008244:0.004738:0.010382:0.003421:0.011665:0.011682:0.016044:0.011203:0.010434:0.005798:0.003421:0.003848:0.013906:0.004738:0.004738
von Gunten C (eds), :@0.121195:0.610407:0.298076:0.610407:0.298076:0.596402:0.121195:0.596402:0.009476:0.011203:0.010434:0.005733:0.014915:0.010399:0.010434:0.005798:0.011118:0.010434:0.005727:0.013906:0.005735:0.006312:0.011118:0.011716:0.006636:0.006312:0.004738:0.004738
Textbook of Palliative :@0.299080:0.610407:0.480482:0.610407:0.480482:0.596402:0.299080:0.596402:0.007286:0.011118:0.008210:0.005798:0.011665:0.011203:0.011203:0.008586:0.005721:0.011203:0.005371:0.005732:0.010126:0.011682:0.003421:0.003421:0.003421:0.011682:0.005798:0.003421:0.009476:0.011118:0.004738
Medicine:@0.121195:0.623977:0.199208:0.623977:0.199208:0.609972:0.121195:0.609972:0.015719:0.011118:0.011716:0.003421:0.011067:0.003421:0.010434:0.011118
. London: Edward Arnold Publish-:@0.199208:0.623977:0.475763:0.623977:0.475763:0.609972:0.199208:0.609972:0.004738:0.005987:0.007902:0.011203:0.010434:0.011716:0.011193:0.010434:0.004738:0.005978:0.009168:0.011716:0.014214:0.011682:0.005051:0.011716:0.005987:0.012657:0.005499:0.010434:0.011203:0.003421:0.011716:0.005987:0.010126:0.010399:0.011665:0.003421:0.003421:0.006636:0.010434:0.005679
ers. 2006;402-414.:@0.121195:0.637547:0.263486:0.637547:0.263486:0.623542:0.121195:0.623542:0.011118:0.005148:0.006636:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
18.   Paice JA, Ferrell B. The management of can-:@0.084848:0.651117:0.475818:0.651117:0.475818:0.637112:0.084848:0.637112:0.009479:0.009479:0.004731:0.004738:0.007916:0.000000:0.009784:0.011340:0.003079:0.010724:0.010776:0.004464:0.007902:0.012315:0.004396:0.004464:0.007954:0.010776:0.004806:0.004736:0.010776:0.003079:0.003079:0.004464:0.009476:0.004396:0.004464:0.006944:0.010092:0.010776:0.004464:0.015702:0.011340:0.010092:0.011340:0.011169:0.010776:0.015702:0.010776:0.010092:0.005456:0.004464:0.010861:0.005029:0.004464:0.010724:0.011340:0.010092:0.005679
cer pain. :@0.121195:0.664688:0.196865:0.664688:0.196865:0.650682:0.121195:0.650682:0.010724:0.010776:0.004806:0.004396:0.011323:0.011340:0.003079:0.010092:0.004396:0.004738
CA Cancer J Clin:@0.196523:0.664688:0.334948:0.664688:0.334948:0.650682:0.196523:0.650682:0.013564:0.012315:0.004396:0.013564:0.011340:0.010092:0.010724:0.010776:0.004806:0.004396:0.007902:0.004396:0.013564:0.003079:0.003079:0.010434
. 2011;61:157-182.:@0.334606:0.664688:0.471869:0.664688:0.471869:0.650682:0.334606:0.650682:0.004396:0.004396:0.009134:0.009134:0.009134:0.009134:0.004396:0.009134:0.009134:0.004396:0.009134:0.009134:0.009134:0.005337:0.009134:0.009134:0.009134:0.004738
19.   National Comprehensive Cancer Network. :@0.084848:0.678258:0.480513:0.678258:0.480513:0.664252:0.084848:0.664252:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.012657:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.005272:0.013906:0.011203:0.016044:0.011665:0.005077:0.011118:0.010434:0.011118:0.010434:0.006636:0.003421:0.009476:0.011118:0.005275:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.005268:0.012657:0.011118:0.005798:0.014214:0.011203:0.005148:0.008586:0.004738:0.004738
(NCCN) Clinical Practice Guideline in On-:@0.121195:0.691828:0.475746:0.691828:0.475746:0.677823:0.121195:0.677823:0.006312:0.012657:0.013906:0.013906:0.012657:0.006312:0.006758:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.006773:0.010126:0.005148:0.011682:0.011067:0.005798:0.003421:0.011067:0.011118:0.006756:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006758:0.003421:0.010434:0.006765:0.014864:0.010434:0.005679
cology. :@0.121195:0.705398:0.188244:0.705398:0.188244:0.691393:0.121195:0.691393:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.004738:0.004738
Adult Cancer Pain V.I.; 2009:@0.188227:0.705398:0.418178:0.705398:0.418178:0.691393:0.188227:0.691393:0.012657:0.011716:0.010399:0.003421:0.005798:0.004738:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.010126:0.011682:0.003421:0.010434:0.004738:0.012007:0.004738:0.003866:0.004738:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476
.:@0.418161:0.705398:0.422899:0.705398:0.422899:0.691393:0.418161:0.691393:0.004738
20.   Hanks GW, De Conno F, Ripamonti C,:@0.084831:0.718968:0.429022:0.718968:0.429022:0.704963:0.084831:0.704963:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.011682:0.011682:0.010434:0.008586:0.006636:0.004994:0.014915:0.014609:0.004738:0.004983:0.012726:0.011118:0.004984:0.013906:0.011203:0.010434:0.010434:0.011203:0.004972:0.006205:0.004738:0.004981:0.010382:0.003421:0.011665:0.011682:0.016044:0.011203:0.010434:0.005798:0.003421:0.004986:0.013906:0.004738
 et al.:@0.429022:0.718968:0.475745:0.718968:0.475745:0.704963:0.429022:0.704963:0.004984:0.011118:0.005798:0.004981:0.011682:0.003421:0.004738
 :@0.475745:0.718968:0.480482:0.718968:0.480482:0.704963:0.475745:0.704963:0.004738
Morphine in cancer pain: modes of admin-:@0.121178:0.732538:0.475753:0.732538:0.475753:0.718533:0.121178:0.718533:0.015719:0.011203:0.005148:0.011665:0.010434:0.003421:0.010434:0.011118:0.004468:0.003421:0.010434:0.004481:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004471:0.011665:0.011682:0.003421:0.010434:0.004738:0.004481:0.016044:0.011203:0.011716:0.011118:0.006636:0.004481:0.011203:0.005371:0.004473:0.011682:0.011716:0.016044:0.003421:0.010434:0.005679
istration:@0.121178:0.746109:0.184721:0.746109:0.184721:0.732103:0.121178:0.732103:0.003421:0.006636:0.005798:0.005148:0.011682:0.005798:0.003421:0.011203:0.010434
. BMJ:@0.184721:0.746109:0.227978:0.746109:0.227978:0.732103:0.184721:0.732103:0.004738:0.004738:0.009818:0.015719:0.008244
. 1996;312:823-826.:@0.227978:0.746109:0.380531:0.746109:0.380531:0.732103:0.227978:0.732103:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
21.   Hanks GW, De Conno  F, Cherny N,:@0.084831:0.759679:0.422812:0.759679:0.422812:0.745674:0.084831:0.745674:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.011682:0.011682:0.010434:0.008586:0.006636:0.008073:0.014915:0.014607:0.004738:0.008073:0.012726:0.011118:0.008073:0.013906:0.011203:0.010434:0.010434:0.011203:0.004738:0.003327:0.006205:0.004738:0.008073:0.013906:0.010434:0.011118:0.005501:0.010434:0.009168:0.008073:0.012657:0.004738
 et al.:@0.422812:0.759679:0.475715:0.759679:0.475715:0.745674:0.422812:0.745674:0.008073:0.011118:0.005798:0.008073:0.011682:0.003421:0.004738
 :@0.475715:0.759679:0.480453:0.759679:0.480453:0.745674:0.475715:0.745674:0.004738
From the Expert Working Group of the Re-:@0.121178:0.773249:0.475743:0.773249:0.475743:0.759244:0.121178:0.759244:0.008296:0.005075:0.011203:0.016044:0.006457:0.005798:0.010434:0.011118:0.006453:0.009168:0.008210:0.011665:0.011118:0.005148:0.005798:0.006457:0.015635:0.011203:0.005148:0.008586:0.003421:0.010434:0.011511:0.006450:0.014915:0.005080:0.011203:0.010399:0.011665:0.006457:0.011203:0.005371:0.006455:0.005798:0.010434:0.011118:0.006455:0.010382:0.011118:0.005679
search Network of the European Associa-:@0.121178:0.786819:0.475760:0.786819:0.475760:0.772814:0.121178:0.772814:0.006636:0.011118:0.011682:0.005030:0.011067:0.010434:0.007252:0.012657:0.011118:0.005798:0.014214:0.011203:0.005148:0.008586:0.007237:0.011203:0.005371:0.007252:0.005798:0.010434:0.011118:0.007242:0.009168:0.010399:0.005078:0.011203:0.011665:0.011118:0.011682:0.010434:0.007252:0.012657:0.006636:0.006636:0.011203:0.011067:0.003421:0.011682:0.005679
tion for Palliative Care. Morphine and alter-:@0.121178:0.800389:0.475755:0.800389:0.475755:0.786384:0.121178:0.786384:0.005798:0.003421:0.011203:0.010434:0.004345:0.005371:0.011203:0.005148:0.004345:0.010126:0.011682:0.003421:0.003421:0.003421:0.011682:0.005798:0.003421:0.009476:0.011118:0.004365:0.013906:0.011682:0.005080:0.011118:0.004738:0.004345:0.015719:0.011203:0.005148:0.011665:0.010434:0.003421:0.010434:0.011118:0.004345:0.011682:0.010434:0.011716:0.004345:0.011682:0.003421:0.005798:0.011118:0.005148:0.005679
native opioids in cancer pain. :@0.121178:0.813960:0.373866:0.813960:0.373866:0.799954:0.121178:0.799954:0.010434:0.011682:0.005798:0.003421:0.009476:0.011118:0.005114:0.011203:0.011665:0.003421:0.011203:0.003421:0.011716:0.006636:0.005114:0.003421:0.010434:0.005114:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005102:0.011665:0.011682:0.003421:0.010434:0.004738:0.004738
Br J Cancer:@0.374242:0.813960:0.471036:0.813960:0.471036:0.799954:0.374242:0.799954:0.009818:0.005148:0.005114:0.008244:0.005114:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148
. :@0.471036:0.813960:0.480512:0.813960:0.480512:0.799954:0.471036:0.799954:0.004738:0.004738
2001;84(5):587-593.:@0.121178:0.827530:0.276879:0.827530:0.276879:0.813524:0.121178:0.813524:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
22.   Scottish Intercollegiate Guidelines Network. :@0.084831:0.841100:0.480501:0.841100:0.480501:0.827095:0.084831:0.827095:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.008518:0.011067:0.011203:0.005798:0.005798:0.003421:0.006636:0.010434:0.003883:0.003866:0.010434:0.005798:0.011118:0.005024:0.011067:0.011203:0.003421:0.003421:0.011118:0.011511:0.003421:0.011682:0.005798:0.011118:0.003883:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.003883:0.012657:0.011118:0.005798:0.014214:0.011203:0.005148:0.008586:0.004738:0.004738
Control of Pain in Adults with Cancer. A Na-:@0.121178:0.854670:0.475767:0.854670:0.475767:0.840665:0.121178:0.840665:0.013906:0.011203:0.010434:0.005798:0.005148:0.011203:0.003421:0.004002:0.011203:0.005371:0.004020:0.010126:0.011682:0.003421:0.010434:0.004020:0.003421:0.010434:0.004020:0.012657:0.011716:0.010399:0.003421:0.005798:0.006636:0.004020:0.014214:0.003421:0.005798:0.010434:0.004020:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.004009:0.012657:0.004011:0.012657:0.011682:0.005679
tional Clinical Guideline:@0.121178:0.868240:0.323984:0.868240:0.323984:0.854235:0.121178:0.854235:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.008056:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.008056:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118
. Edinburgh,  Scot-:@0.323984:0.868240:0.475741:0.868240:0.475741:0.854235:0.323984:0.854235:0.004738:0.008056:0.009168:0.011716:0.003421:0.010434:0.011665:0.010399:0.005167:0.011511:0.010434:0.004738:0.004738:0.003306:0.008518:0.011067:0.011203:0.005798:0.005679
land: SIGN – Scottish Intercollegiate Guide-:@0.121178:0.881810:0.475745:0.881810:0.475745:0.867805:0.121178:0.867805:0.003421:0.011682:0.010434:0.011716:0.004738:0.004789:0.008518:0.003866:0.014915:0.012657:0.004789:0.008552:0.004789:0.008518:0.011067:0.011203:0.005798:0.005798:0.003421:0.006636:0.010434:0.004789:0.003866:0.010434:0.005798:0.011118:0.005022:0.011067:0.011203:0.003421:0.003421:0.011118:0.011511:0.003421:0.011682:0.005798:0.011118:0.004789:0.014915:0.010399:0.003421:0.011716:0.011118:0.005679
lines Network; November 2008.:@0.121178:0.895381:0.374955:0.895381:0.374955:0.881375:0.121178:0.881375:0.003421:0.003421:0.010434:0.011118:0.006636:0.004738:0.012657:0.011118:0.005798:0.014214:0.011203:0.005148:0.008586:0.004738:0.004738:0.012657:0.011203:0.009476:0.011118:0.016044:0.011665:0.011118:0.005148:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738
23.   Caraceni A, Hanks G, Kaasa S,:@0.084831:0.908951:0.413782:0.908951:0.413782:0.894946:0.084831:0.894946:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.013906:0.011682:0.005148:0.011682:0.011067:0.011118:0.010434:0.003421:0.012606:0.012657:0.004738:0.012606:0.011682:0.011682:0.010434:0.008586:0.006636:0.012606:0.014915:0.004738:0.012606:0.010109:0.011682:0.011682:0.006636:0.011682:0.012606:0.008518:0.004738
 et al.:@0.413782:0.908951:0.475751:0.908951:0.475751:0.894946:0.413782:0.894946:0.012606:0.011118:0.005798:0.012606:0.011682:0.003421:0.004738
 :@0.475751:0.908951:0.480489:0.908951:0.480489:0.894946:0.475751:0.894946:0.004738
Use of opioid analgesics  in the treat-:@0.121178:0.922521:0.475726:0.922521:0.475726:0.908516:0.121178:0.908516:0.011203:0.006636:0.011118:0.013735:0.011203:0.005371:0.013735:0.011203:0.011665:0.003421:0.011203:0.003421:0.011716:0.013735:0.011682:0.010434:0.011682:0.003421:0.011511:0.011118:0.006636:0.003421:0.011067:0.006636:0.004738:0.009011:0.003421:0.010434:0.013735:0.005798:0.010434:0.011118:0.013735:0.005798:0.005075:0.011118:0.011682:0.005798:0.005679
ment of cancer pain: evidence-based :@0.121178:0.936091:0.480489:0.936091:0.480489:0.922086:0.121178:0.922086:0.016044:0.011118:0.010434:0.005798:0.013547:0.011203:0.005371:0.013547:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.013547:0.011665:0.011682:0.003421:0.010434:0.004738:0.013547:0.011118:0.009476:0.003421:0.011716:0.011118:0.010434:0.011067:0.011118:0.005679:0.011665:0.011682:0.006636:0.011118:0.011716:0.004738
recommendations from the EAPC. :@0.560572:0.094916:0.854895:0.094916:0.854895:0.080911:0.560572:0.080911:0.005078:0.011118:0.011067:0.011203:0.016044:0.016044:0.011118:0.010434:0.011716:0.011682:0.005798:0.003421:0.011203:0.010434:0.006636:0.006980:0.005371:0.005077:0.011203:0.016044:0.006985:0.005798:0.010434:0.011118:0.006984:0.009168:0.012657:0.010126:0.013906:0.004738:0.004738
Lancet :@0.857144:0.094916:0.919883:0.094916:0.919883:0.080911:0.857144:0.080911:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798:0.004738
Oncol:@0.560572:0.108592:0.611560:0.108592:0.611560:0.094587:0.560572:0.094587:0.014864:0.010434:0.011067:0.011203:0.003421
. 2012;13:58-68.:@0.611560:0.108592:0.735686:0.108592:0.735686:0.094587:0.611560:0.094587:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
24.   Portenoy  RK,  Hagen  NA.  Breakthrough :@0.524225:0.122268:0.919885:0.122268:0.919885:0.108263:0.524225:0.108263:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010126:0.011203:0.005148:0.005798:0.011118:0.010434:0.011203:0.009168:0.004738:0.009635:0.010382:0.010109:0.004738:0.004738:0.009650:0.011682:0.011682:0.011511:0.011118:0.010434:0.004738:0.009650:0.012657:0.012657:0.004738:0.004738:0.009642:0.009818:0.005082:0.011118:0.011682:0.008586:0.005798:0.010434:0.005073:0.011203:0.010399:0.011511:0.010434:0.004738
pain:  definition,  prevalence,  and  charac-:@0.560572:0.135944:0.915137:0.135944:0.915137:0.121939:0.560572:0.121939:0.011665:0.011682:0.003421:0.010434:0.004738:0.004738:0.002892:0.011716:0.011118:0.004165:0.004165:0.010434:0.003421:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738:0.002882:0.011665:0.005080:0.011118:0.009476:0.011682:0.003421:0.011118:0.010434:0.011067:0.011118:0.004738:0.004738:0.002889:0.011682:0.010434:0.011716:0.004738:0.002891:0.011067:0.010434:0.011682:0.005148:0.011682:0.011067:0.005679
teristics. :@0.560572:0.149620:0.629092:0.149620:0.629092:0.135615:0.560572:0.135615:0.005798:0.011118:0.005148:0.003421:0.006636:0.005798:0.003421:0.011067:0.006636:0.004738:0.004738
Pain:@0.629092:0.149620:0.664755:0.149620:0.664755:0.135615:0.629092:0.135615:0.010126:0.011682:0.003421:0.010434
. 1990;41:273-281.:@0.664755:0.149620:0.807833:0.149620:0.807833:0.135615:0.664755:0.135615:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
25.   Joint Formulary Committee. :@0.524225:0.163296:0.794736:0.163296:0.794736:0.149291:0.524225:0.149291:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.008244:0.011203:0.003421:0.010434:0.005798:0.005080:0.008296:0.011203:0.005615:0.016044:0.010399:0.003421:0.011682:0.005148:0.009168:0.005080:0.013906:0.011203:0.016044:0.016044:0.003421:0.005798:0.005798:0.011118:0.011118:0.004738:0.004738
British National :@0.795078:0.163296:0.919871:0.163296:0.919871:0.149291:0.795078:0.149291:0.009818:0.005148:0.003421:0.005798:0.003421:0.006636:0.010434:0.005080:0.012657:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.004738
Formulary. :@0.560572:0.176972:0.650558:0.176972:0.650558:0.162967:0.560572:0.162967:0.008296:0.011203:0.005148:0.016044:0.010399:0.003421:0.011682:0.005148:0.009168:0.004738:0.004738
55th ed. London: British Medical :@0.651037:0.176972:0.919871:0.176972:0.919871:0.162967:0.651037:0.162967:0.009476:0.009476:0.005798:0.010434:0.005234:0.011118:0.011716:0.004738:0.005222:0.007902:0.011203:0.010434:0.011716:0.011203:0.010434:0.004723:0.005225:0.009818:0.005148:0.003421:0.005798:0.003421:0.006636:0.010434:0.005224:0.015719:0.011118:0.011716:0.003421:0.011067:0.011682:0.003421:0.004738
Association and Royal Pharmaceutical So-:@0.560572:0.190648:0.915135:0.190648:0.915135:0.176643:0.560572:0.176643:0.012657:0.006636:0.006636:0.011203:0.011067:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.005439:0.011682:0.010434:0.011716:0.005439:0.010382:0.011203:0.009168:0.011682:0.003421:0.005439:0.010126:0.010434:0.011682:0.005617:0.016044:0.011682:0.011067:0.011118:0.010399:0.005798:0.003421:0.011067:0.011682:0.003421:0.005439:0.008518:0.011203:0.005679
ciety of Great Britain; 2007.:@0.560572:0.204324:0.782356:0.204324:0.782356:0.190319:0.560572:0.190319:0.011067:0.003421:0.011118:0.005798:0.009168:0.004738:0.011203:0.005371:0.004738:0.014915:0.005071:0.011118:0.011682:0.005798:0.004738:0.009818:0.005148:0.003421:0.005798:0.011682:0.003421:0.010434:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738
26.   Ripamonti C, Bareggi C. Pharmacology :@0.524225:0.218000:0.919892:0.218000:0.919892:0.203995:0.524225:0.203995:0.009479:0.009479:0.004731:0.004738:0.007916:0.000000:0.010211:0.003250:0.011494:0.011511:0.015873:0.011032:0.010263:0.005627:0.003250:0.012811:0.013735:0.004567:0.012811:0.009647:0.011511:0.004906:0.010947:0.011340:0.011340:0.003250:0.012811:0.013735:0.004567:0.012811:0.009955:0.010263:0.011511:0.005449:0.015873:0.011511:0.010895:0.011032:0.003250:0.011032:0.011340:0.009170:0.004738
of opioid analgesia: clinical principles. In: :@0.560572:0.231676:0.919880:0.231676:0.919880:0.217671:0.560572:0.217671:0.011032:0.005200:0.009202:0.011032:0.011494:0.003250:0.011032:0.003250:0.011545:0.009202:0.011511:0.010263:0.011511:0.003250:0.011340:0.010947:0.006465:0.003250:0.011511:0.004567:0.009202:0.010895:0.003250:0.003250:0.010263:0.003250:0.010895:0.011511:0.003250:0.009202:0.011494:0.004977:0.003250:0.010263:0.010895:0.003250:0.011494:0.003250:0.010947:0.006465:0.004567:0.009202:0.003695:0.010263:0.004734:0.004738
Bruera  E,  Portenoy  RK.:@0.560572:0.245352:0.756490:0.245352:0.756490:0.231347:0.560572:0.231347:0.009647:0.004977:0.010228:0.010947:0.004977:0.011511:0.004738:0.006045:0.008997:0.004567:0.004738:0.006045:0.009955:0.011032:0.004977:0.005627:0.010947:0.010263:0.011032:0.008997:0.004738:0.006046:0.010211:0.009938:0.004738
  Cancer  Pain:  As-:@0.756319:0.245352:0.915173:0.245352:0.915173:0.231347:0.756319:0.231347:0.004738:0.006045:0.013735:0.011511:0.010263:0.010895:0.010947:0.004977:0.004738:0.006045:0.009955:0.011511:0.003250:0.010263:0.004567:0.004738:0.006046:0.012486:0.006465:0.005679
sessment  and  Management. :@0.560572:0.259028:0.810343:0.259028:0.810343:0.245023:0.560572:0.245023:0.006465:0.010947:0.006465:0.006465:0.015873:0.010947:0.010263:0.005627:0.004738:0.005395:0.011511:0.010263:0.011545:0.004738:0.005395:0.015548:0.011511:0.010263:0.011511:0.011340:0.010947:0.015873:0.010947:0.010263:0.005627:0.004567:0.004738
Cambridge, :@0.815718:0.259028:0.919863:0.259028:0.919863:0.245023:0.815718:0.245023:0.013735:0.011511:0.015873:0.011494:0.004977:0.003250:0.011545:0.011340:0.010947:0.004734:0.004738
Cambridge University Press. 2010;11:195-229.:@0.560572:0.272704:0.915091:0.272704:0.915091:0.258699:0.560572:0.258699:0.013735:0.011511:0.015873:0.011494:0.004977:0.003250:0.011545:0.011340:0.010947:0.003797:0.011032:0.010263:0.003250:0.009305:0.010947:0.004977:0.006465:0.003250:0.005627:0.008997:0.003797:0.009955:0.004906:0.010947:0.006465:0.006465:0.004567:0.003797:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.009305:0.004567:0.009305:0.009305:0.009305:0.005508:0.009305:0.009305:0.009305:0.004738
27.   Mercadante S, Radbruch I, Caraceni A,:@0.524225:0.286380:0.892898:0.286380:0.892898:0.272375:0.524225:0.272375:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015719:0.011118:0.005025:0.011067:0.011682:0.011716:0.011682:0.010434:0.005798:0.011118:0.005354:0.008518:0.004738:0.005354:0.010382:0.011682:0.011716:0.011665:0.005148:0.010399:0.011067:0.010434:0.005345:0.003866:0.004738:0.005354:0.013906:0.011682:0.005148:0.011682:0.011067:0.011118:0.010434:0.003421:0.005354:0.012657:0.004738
 et :@0.892898:0.286380:0.919905:0.286380:0.919905:0.272375:0.892898:0.272375:0.005354:0.011118:0.005798:0.004738
al.:@0.560572:0.300056:0.580413:0.300056:0.580413:0.286051:0.560572:0.286051:0.011682:0.003421:0.004738
 Episodic breakthrough pain: consensus :@0.580413:0.300056:0.919876:0.300056:0.919876:0.286051:0.580413:0.286051:0.006739:0.009168:0.011665:0.003421:0.006636:0.011203:0.011716:0.003421:0.011067:0.006739:0.011665:0.005080:0.011118:0.011682:0.008586:0.005798:0.010434:0.005071:0.011203:0.010399:0.011511:0.010434:0.006724:0.011665:0.011682:0.003421:0.010434:0.004738:0.006739:0.011067:0.011203:0.010434:0.006636:0.011118:0.010434:0.006636:0.010399:0.006636:0.004738
conference of an export working group :@0.560572:0.313732:0.919885:0.313732:0.919885:0.299727:0.560572:0.299727:0.011067:0.011203:0.010434:0.005371:0.011118:0.005070:0.011118:0.010434:0.011067:0.011118:0.010074:0.011203:0.005371:0.010074:0.011682:0.010434:0.010074:0.011118:0.008210:0.011665:0.011203:0.005148:0.005798:0.010074:0.014214:0.011203:0.005148:0.008586:0.003421:0.010434:0.011511:0.010074:0.011511:0.005075:0.011203:0.010399:0.011665:0.004738
of the European Association for Palliative :@0.560572:0.327408:0.919881:0.327408:0.919881:0.313403:0.560572:0.313403:0.011203:0.005371:0.008090:0.005798:0.010434:0.011118:0.008090:0.009168:0.010399:0.005078:0.011203:0.011665:0.011118:0.011682:0.010434:0.008090:0.012657:0.006636:0.006636:0.011203:0.011067:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.008090:0.005371:0.011203:0.005148:0.008090:0.010126:0.011682:0.003421:0.003421:0.003421:0.011682:0.005798:0.003421:0.009476:0.011118:0.004738
Care. :@0.560572:0.341084:0.611834:0.341084:0.611834:0.327079:0.560572:0.327079:0.013906:0.011682:0.005080:0.011118:0.004738:0.004738
Cancer:@0.611834:0.341084:0.675188:0.341084:0.675188:0.327079:0.611834:0.327079:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148
. 2002;94:832-839.:@0.675188:0.341084:0.818266:0.341084:0.818266:0.327079:0.675188:0.327079:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
28.   Mercadante S, Villari P, Ferrera P,:@0.524225:0.354761:0.857398:0.354761:0.857398:0.340755:0.524225:0.340755:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015719:0.011118:0.005025:0.011067:0.011682:0.011716:0.011682:0.010434:0.005798:0.011118:0.010502:0.008518:0.004738:0.010502:0.012093:0.003421:0.003421:0.003421:0.011682:0.005148:0.003421:0.010502:0.008019:0.004738:0.010502:0.008296:0.011118:0.005148:0.005070:0.011118:0.005148:0.011682:0.010502:0.008019:0.004738
 et  al.:@0.857398:0.354761:0.915150:0.354761:0.915150:0.340755:0.857398:0.340755:0.010502:0.011118:0.005798:0.004738:0.005756:0.011682:0.003421:0.004738
 :@0.915150:0.354761:0.919888:0.354761:0.919888:0.340755:0.915150:0.340755:0.004738
Transmucosal fentanyl vs intravenous mor-:@0.560572:0.368437:0.915138:0.368437:0.915138:0.354431:0.560572:0.354431:0.006773:0.005148:0.011682:0.010434:0.006636:0.016044:0.010399:0.011067:0.011203:0.006636:0.011682:0.003421:0.006517:0.005371:0.011118:0.010434:0.005798:0.011682:0.010434:0.009168:0.003421:0.006517:0.009476:0.006636:0.006527:0.003421:0.010434:0.005798:0.005148:0.011682:0.009476:0.011118:0.010434:0.011203:0.010399:0.006636:0.006517:0.016044:0.011203:0.005148:0.005679
phine in doses proportional to basal opioid :@0.560572:0.382113:0.919864:0.382113:0.919864:0.368107:0.560572:0.368107:0.011665:0.010434:0.003421:0.010434:0.011118:0.004943:0.003421:0.010434:0.004943:0.011716:0.011203:0.006636:0.011118:0.006636:0.004943:0.011665:0.005080:0.011203:0.011665:0.011203:0.005148:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.004943:0.005798:0.011203:0.004943:0.011665:0.011682:0.006636:0.011682:0.003421:0.004959:0.011203:0.011665:0.003421:0.011203:0.003421:0.011716:0.004738
regimen  for  episodic  breakthrough  pain.  :@0.560572:0.395789:0.919866:0.395789:0.919866:0.381783:0.560572:0.381783:0.005078:0.011118:0.011511:0.003421:0.016044:0.011118:0.010434:0.004738:0.004996:0.005371:0.011203:0.005148:0.004738:0.004993:0.011118:0.011665:0.003421:0.006636:0.011203:0.011716:0.003421:0.011067:0.004738:0.005003:0.011665:0.005080:0.011118:0.011682:0.008586:0.005798:0.010434:0.005071:0.011203:0.010399:0.011511:0.010434:0.004738:0.004998:0.011665:0.011682:0.003421:0.010434:0.004738:0.000000:0.004738
Br J Cancer:@0.560572:0.409465:0.656613:0.409465:0.656613:0.395459:0.560572:0.395459:0.009818:0.005148:0.004738:0.008244:0.004738:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148
. 2007;12:1828-1833.:@0.656596:0.409465:0.818625:0.409465:0.818625:0.395459:0.656596:0.395459:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
29.   Zeppetella G, Riberio MDC. Opioids for the :@0.524225:0.423141:0.919888:0.423141:0.919888:0.409135:0.524225:0.409135:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.008210:0.011118:0.011665:0.011665:0.011118:0.005798:0.011118:0.003421:0.003421:0.011682:0.005046:0.014915:0.004738:0.005046:0.010382:0.003421:0.011665:0.011118:0.005148:0.003421:0.011203:0.005046:0.015719:0.012726:0.013906:0.004738:0.005046:0.014864:0.011665:0.003421:0.011203:0.003421:0.011716:0.006636:0.005046:0.005371:0.011203:0.005148:0.005034:0.005798:0.010434:0.011118:0.004738
management of breakthrough episodic :@0.560572:0.436817:0.919875:0.436817:0.919875:0.422811:0.560572:0.422811:0.016044:0.011682:0.010434:0.011682:0.011511:0.011118:0.016044:0.011118:0.010434:0.005798:0.012965:0.011203:0.005371:0.012965:0.011665:0.005080:0.011118:0.011682:0.008586:0.005798:0.010434:0.005071:0.011203:0.010399:0.011511:0.010434:0.012965:0.011118:0.011665:0.003421:0.006636:0.011203:0.011716:0.003421:0.011067:0.004738
pain in cancer  patients. :@0.560572:0.450493:0.771664:0.450493:0.771664:0.436487:0.560572:0.436487:0.011665:0.011682:0.003421:0.010434:0.007834:0.003421:0.010434:0.007834:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.003086:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.004738:0.004738
Cochrane Data-:@0.774760:0.450493:0.915144:0.450493:0.915144:0.436487:0.774760:0.436487:0.013906:0.011203:0.011067:0.010434:0.005148:0.011674:0.010434:0.011118:0.007834:0.012726:0.011682:0.005798:0.011682:0.005679
base Syst Rev.:@0.560572:0.464169:0.676984:0.464169:0.676984:0.450163:0.560572:0.450163:0.011665:0.011682:0.006636:0.011118:0.004738:0.008518:0.009168:0.006636:0.005798:0.004738:0.010382:0.011118:0.009476:0.004738
 2006;1:CDOO4311.:@0.676984:0.464169:0.837577:0.464169:0.837577:0.450163:0.676984:0.450163:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.013906:0.012726:0.014864:0.014864:0.009476:0.009476:0.009476:0.009476:0.004738
30.   Chetty  S,  Baalbergen  E, Bhigjee AI, :@0.524225:0.477845:0.867515:0.477845:0.867515:0.463839:0.524225:0.463839:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.013906:0.010434:0.011118:0.005798:0.005798:0.009168:0.004738:0.003065:0.008518:0.004738:0.004738:0.003070:0.009818:0.011682:0.011682:0.003421:0.011665:0.011118:0.005172:0.011511:0.011118:0.010434:0.004738:0.003065:0.009168:0.004738:0.007817:0.009818:0.010434:0.003421:0.011511:0.003472:0.011118:0.011118:0.007817:0.012657:0.003866:0.004738:0.004738
et  al:@0.870571:0.477845:0.910397:0.477845:0.910397:0.463839:0.870571:0.463839:0.011118:0.005798:0.004738:0.003069:0.011682:0.003421
. :@0.910397:0.477845:0.919873:0.477845:0.919873:0.463839:0.910397:0.463839:0.004738:0.004738
Clinical  practice guidelines for manage-:@0.560572:0.491521:0.915140:0.491521:0.915140:0.477515:0.560572:0.477515:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.004738:0.005212:0.011665:0.005148:0.011682:0.011067:0.005798:0.003421:0.011067:0.011118:0.009938:0.011511:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.009938:0.005371:0.011203:0.005148:0.009938:0.016044:0.011682:0.010434:0.011682:0.011511:0.011118:0.005679
ment  of neuropathic pain: expert  panel :@0.560572:0.505197:0.919875:0.505197:0.919875:0.491191:0.560572:0.491191:0.016044:0.011118:0.010434:0.005798:0.004738:0.005054:0.011203:0.005371:0.009801:0.010434:0.011118:0.010399:0.005071:0.011203:0.011665:0.011682:0.005798:0.010434:0.003421:0.011067:0.009801:0.011665:0.011682:0.003421:0.010434:0.004738:0.009801:0.011118:0.008210:0.011665:0.011118:0.005148:0.005798:0.004738:0.005054:0.011665:0.011682:0.010434:0.011118:0.003421:0.004738
recommendations  for  South  Africa. :@0.560572:0.518873:0.867036:0.518873:0.867036:0.504867:0.560572:0.504867:0.005078:0.011118:0.011067:0.011203:0.016044:0.016044:0.011118:0.010434:0.011716:0.011682:0.005798:0.003421:0.011203:0.010434:0.006636:0.004738:0.004119:0.005371:0.011203:0.005148:0.004738:0.004119:0.008518:0.011203:0.010399:0.005798:0.010434:0.004738:0.004119:0.012657:0.005371:0.005148:0.003421:0.011067:0.011682:0.004738:0.004738
S  Afri :@0.871153:0.518873:0.919873:0.518873:0.919873:0.504867:0.871153:0.504867:0.008518:0.004738:0.004129:0.012657:0.005371:0.005148:0.003421:0.004738
Med J.:@0.560572:0.532549:0.616845:0.532549:0.616845:0.518543:0.560572:0.518543:0.015719:0.011118:0.011716:0.004738:0.008244:0.004738
 2012;102(5):312-325.:@0.616845:0.532549:0.786760:0.532549:0.786760:0.518543:0.616845:0.518543:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
31.   Vainio A, Tigerstedt I. Opioid treatment for :@0.524225:0.546225:0.919878:0.546225:0.919878:0.532219:0.524225:0.532219:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010230:0.011682:0.003421:0.010434:0.003421:0.011203:0.006209:0.012657:0.004738:0.006200:0.007808:0.003421:0.011511:0.011118:0.005148:0.006636:0.005798:0.011118:0.011716:0.005798:0.006200:0.003866:0.004738:0.006209:0.014864:0.011665:0.003421:0.011203:0.003421:0.011716:0.006209:0.005798:0.005077:0.011118:0.011682:0.005798:0.016044:0.011118:0.010434:0.005798:0.006197:0.005371:0.011203:0.005148:0.004738
radiating cancer pain: oral administration :@0.560572:0.559901:0.919883:0.559901:0.919883:0.545896:0.560572:0.545896:0.005148:0.011682:0.011716:0.003421:0.011682:0.005798:0.003421:0.010434:0.011511:0.007252:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.007252:0.011665:0.011682:0.003421:0.010434:0.004738:0.007252:0.011203:0.005148:0.011682:0.003421:0.007252:0.011682:0.011716:0.016044:0.003421:0.010434:0.003421:0.006636:0.005798:0.005148:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738
vs epidural techniques. :@0.560572:0.573577:0.760462:0.573577:0.760462:0.559572:0.560572:0.559572:0.009476:0.006636:0.006825:0.011118:0.011665:0.003421:0.011716:0.010399:0.005148:0.011682:0.003421:0.006825:0.005798:0.011118:0.011067:0.010434:0.010425:0.003421:0.011665:0.010399:0.011118:0.006636:0.004738:0.004738
Acta Anaesthesiol :@0.762549:0.573577:0.919875:0.573577:0.919875:0.559572:0.762549:0.559572:0.012657:0.011067:0.005798:0.011682:0.006825:0.012657:0.010434:0.011682:0.011118:0.006636:0.005798:0.010434:0.011118:0.006636:0.003421:0.011203:0.003421:0.004738
Scand:@0.560572:0.587253:0.613989:0.587253:0.613989:0.573248:0.560572:0.573248:0.008518:0.011067:0.011682:0.010434:0.011716
. 1988;32:179-180.:@0.613989:0.587253:0.757067:0.587253:0.757067:0.573248:0.613989:0.573248:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
32.   Myers J, Chan V, Jarvis V,:@0.524225:0.600929:0.774724:0.600929:0.774724:0.586924:0.524225:0.586924:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015719:0.009168:0.011118:0.005148:0.006636:0.006488:0.008244:0.004738:0.006486:0.013906:0.010434:0.011682:0.010434:0.006486:0.010198:0.004738:0.006486:0.008244:0.011682:0.005148:0.009476:0.003421:0.006636:0.006500:0.010198:0.004738
 et al.:@0.774724:0.600929:0.824460:0.600929:0.824460:0.586924:0.774724:0.586924:0.006489:0.011118:0.005798:0.006489:0.011682:0.003421:0.004738
 Intraspinal :@0.824460:0.600929:0.919875:0.600929:0.919875:0.586924:0.824460:0.586924:0.006489:0.003866:0.010434:0.005798:0.005148:0.011682:0.006636:0.011665:0.003421:0.010434:0.011682:0.003421:0.004738
techniques for pain management in can-:@0.560572:0.614605:0.915145:0.614605:0.915145:0.600600:0.560572:0.600600:0.005798:0.011118:0.011067:0.010434:0.010434:0.003421:0.011665:0.010399:0.011118:0.006636:0.006996:0.005371:0.011203:0.005148:0.006996:0.011665:0.011682:0.003421:0.010434:0.006996:0.016044:0.011682:0.010434:0.011682:0.011511:0.011118:0.016044:0.011118:0.010434:0.005798:0.006996:0.003421:0.010434:0.006996:0.011067:0.011682:0.010434:0.005679
cer patients: a systematic review. :@0.560572:0.628281:0.848818:0.628281:0.848818:0.614276:0.560572:0.614276:0.011067:0.011118:0.005148:0.006660:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.004738:0.006671:0.011682:0.006671:0.006636:0.009168:0.006636:0.005798:0.011118:0.016044:0.011682:0.005798:0.003421:0.011067:0.006671:0.005077:0.011118:0.009476:0.003421:0.011118:0.014214:0.004738:0.004738
Support :@0.850751:0.628281:0.919887:0.628281:0.919887:0.614276:0.850751:0.614276:0.008518:0.010399:0.011665:0.011665:0.011203:0.005148:0.005798:0.004738
Care Cancer:@0.560572:0.641957:0.670519:0.641957:0.670519:0.627952:0.560572:0.627952:0.013906:0.011682:0.005148:0.011118:0.004738:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148
. 2010;18:137-149.:@0.670502:0.641957:0.813580:0.641957:0.813580:0.627952:0.670502:0.627952:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
33.   Ripamonti CI, Santini D, Maranzano E, :@0.524225:0.655633:0.874266:0.655633:0.874266:0.641628:0.524225:0.641628:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010382:0.003421:0.011665:0.011682:0.016044:0.011203:0.010434:0.005798:0.003421:0.004413:0.013906:0.003866:0.004738:0.004413:0.008518:0.011682:0.010434:0.005798:0.003421:0.010434:0.003421:0.004413:0.012726:0.004738:0.004413:0.015719:0.011682:0.005148:0.011682:0.010434:0.007269:0.011682:0.010434:0.011203:0.004413:0.009168:0.004738:0.004738
et al:@0.873941:0.655633:0.910373:0.655633:0.910373:0.641628:0.873941:0.641628:0.011118:0.005798:0.004413:0.011682:0.003421
. :@0.910373:0.655633:0.919849:0.655633:0.919849:0.641628:0.910373:0.641628:0.004738:0.004738
On  behalf of  the  ESMO Guidelines  Work-:@0.560572:0.669309:0.915128:0.669309:0.915128:0.655304:0.560572:0.655304:0.014864:0.010434:0.004738:0.003684:0.011665:0.011118:0.010434:0.011682:0.003421:0.005371:0.008432:0.011203:0.005371:0.004738:0.003679:0.005798:0.010434:0.011118:0.004738:0.003681:0.009168:0.008518:0.015719:0.014864:0.008432:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.004738:0.003686:0.015635:0.011203:0.005148:0.008564:0.005679
ing  Group. Management  of  cancer  pain: :@0.560572:0.682985:0.919881:0.682985:0.919881:0.668980:0.560572:0.668980:0.003421:0.010434:0.011511:0.004738:0.002591:0.014915:0.005078:0.011203:0.010399:0.011665:0.004738:0.007338:0.015719:0.011682:0.010434:0.011682:0.011511:0.011118:0.016044:0.011118:0.010434:0.005798:0.004738:0.002583:0.011203:0.005371:0.004738:0.002588:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.002586:0.011665:0.011682:0.003421:0.010434:0.004738:0.004738
ESMO Clinical Practice Guidelines. :@0.560572:0.696661:0.855911:0.696661:0.855911:0.682656:0.560572:0.682656:0.009168:0.008518:0.015719:0.014864:0.006927:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.006943:0.010126:0.005148:0.011682:0.011067:0.005798:0.003421:0.011067:0.011118:0.006927:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.004738:0.004738
Ann of :@0.858101:0.696661:0.919864:0.696661:0.919864:0.682656:0.858101:0.682656:0.012657:0.010434:0.010434:0.006927:0.011203:0.005371:0.004738
Oncol:@0.560572:0.710337:0.611560:0.710337:0.611560:0.696332:0.560572:0.696332:0.014864:0.010434:0.011067:0.011203:0.003421
. 2012;23(Suppl7):vii139-vii154.:@0.611560:0.710337:0.855041:0.710337:0.855041:0.696332:0.611560:0.696332:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.008518:0.010399:0.011665:0.011665:0.003421:0.009476:0.006312:0.004738:0.009476:0.003421:0.003421:0.009476:0.009476:0.009476:0.005679:0.009476:0.003421:0.003421:0.009476:0.009476:0.009476:0.004738
34.   Smith  TJ,:@0.524225:0.724013:0.632857:0.724013:0.632857:0.710008:0.524225:0.710008:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.008518:0.016044:0.003421:0.005798:0.010434:0.004738:0.003063:0.007286:0.008244:0.004738
 et al. :@0.632857:0.724013:0.689951:0.724013:0.689951:0.710008:0.632857:0.710008:0.007800:0.011118:0.005798:0.007800:0.011682:0.003421:0.004738:0.004738
American Society of Clini-:@0.693013:0.724013:0.915130:0.724013:0.915130:0.710008:0.693013:0.710008:0.012657:0.016044:0.011118:0.005148:0.003421:0.011067:0.011682:0.010434:0.007800:0.008518:0.011203:0.011067:0.003421:0.011118:0.005798:0.009168:0.007800:0.011203:0.005371:0.007800:0.013906:0.003421:0.003421:0.010434:0.003421:0.005679
cal Oncology provisional clinical opin-:@0.560572:0.737689:0.915128:0.737689:0.915128:0.723684:0.560572:0.723684:0.011067:0.011682:0.003421:0.014385:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.014385:0.011665:0.005080:0.011203:0.009476:0.003421:0.006636:0.003421:0.011203:0.010434:0.011682:0.003421:0.014385:0.011067:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.014385:0.011203:0.011665:0.003421:0.010434:0.005679
ion: the integration  of palliative  care into :@0.560572:0.751365:0.919890:0.751365:0.919890:0.737360:0.560572:0.737360:0.003421:0.011203:0.010434:0.004738:0.007663:0.005798:0.010434:0.011118:0.007663:0.003421:0.010434:0.005798:0.011118:0.011511:0.005148:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738:0.002913:0.011203:0.005371:0.007663:0.011665:0.011682:0.003421:0.003421:0.003421:0.011682:0.005798:0.003421:0.009476:0.011118:0.004738:0.002945:0.011067:0.011682:0.005078:0.011118:0.007663:0.003421:0.010434:0.005798:0.011203:0.004738
standard oncology  care:@0.560572:0.765041:0.778160:0.765041:0.778160:0.751036:0.560572:0.751036:0.006636:0.005798:0.011682:0.010434:0.011716:0.011682:0.005047:0.011716:0.012366:0.011203:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.004738:0.007615:0.011067:0.011682:0.005078:0.011118
. J Clin Oncol:@0.778160:0.765041:0.910411:0.765041:0.910411:0.751036:0.778160:0.751036:0.004738:0.012366:0.008244:0.012366:0.013906:0.003421:0.003421:0.010434:0.012366:0.014864:0.010434:0.011067:0.011203:0.003421
. :@0.910411:0.765041:0.919887:0.765041:0.919887:0.751036:0.910411:0.751036:0.004738:0.004738
2012;30(8):880-7.:@0.560572:0.778717:0.697321:0.778717:0.697321:0.764712:0.560572:0.764712:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.004738
35.   Temel JS,:@0.524225:0.792393:0.635814:0.792393:0.635814:0.778388:0.524225:0.778388:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.006447:0.011118:0.016044:0.011118:0.003421:0.005595:0.008244:0.008518:0.004738
 et al. :@0.635814:0.792393:0.688495:0.792393:0.688495:0.778388:0.635814:0.778388:0.005593:0.011118:0.005798:0.005593:0.011682:0.003421:0.004738:0.004738
Early palliative care for pa-:@0.689351:0.792393:0.915130:0.792393:0.915130:0.778388:0.689351:0.778388:0.009168:0.011682:0.005148:0.003421:0.009168:0.005593:0.011665:0.011682:0.003421:0.003421:0.003421:0.011682:0.005798:0.003421:0.009476:0.011118:0.005612:0.011067:0.011682:0.005080:0.011118:0.005593:0.005371:0.011203:0.005148:0.005593:0.011665:0.011682:0.005679
tients with metastatic non-small-cell  lung :@0.560572:0.806069:0.919859:0.806069:0.919859:0.792064:0.560572:0.792064:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.009749:0.014214:0.003421:0.005798:0.010434:0.009749:0.016044:0.011118:0.005798:0.011682:0.006636:0.005798:0.011682:0.005798:0.003421:0.011067:0.009749:0.010434:0.011203:0.010434:0.005679:0.006636:0.016044:0.011682:0.003421:0.003421:0.005679:0.011067:0.011118:0.003421:0.003421:0.004738:0.005022:0.003421:0.010399:0.010434:0.011511:0.004738
cancer:@0.560572:0.820486:0.621087:0.820486:0.621087:0.806481:0.560572:0.806481:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148
. Engl J Med:@0.621087:0.820486:0.721370:0.820486:0.721370:0.806481:0.621087:0.806481:0.004738:0.004738:0.009168:0.010434:0.011511:0.003421:0.004738:0.008244:0.004738:0.015719:0.011118:0.011716
. 2010;363(8):733-42.:@0.721353:0.820486:0.886530:0.820486:0.886530:0.806481:0.721353:0.806481:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
36.   Girgis A,:@0.524225:0.834903:0.628928:0.834903:0.628928:0.820898:0.524225:0.820898:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.014915:0.003421:0.005166:0.011511:0.003421:0.006636:0.005891:0.012657:0.004738
 et al. :@0.628928:0.834903:0.682191:0.834903:0.682191:0.820898:0.628928:0.820898:0.005884:0.011118:0.005798:0.005884:0.011682:0.003421:0.004738:0.004738
Physical, psychosocial, rela-:@0.683337:0.834903:0.915116:0.834903:0.915116:0.820898:0.683337:0.820898:0.010126:0.010434:0.009168:0.006636:0.003421:0.011067:0.011682:0.003421:0.004738:0.005884:0.011665:0.006636:0.009168:0.011067:0.010434:0.011203:0.006636:0.011203:0.011067:0.003421:0.011682:0.003421:0.004738:0.005884:0.005078:0.011118:0.003421:0.011682:0.005679
tionship,  and  economic  burden  of  caring :@0.560572:0.849320:0.919878:0.849320:0.919878:0.835314:0.560572:0.835314:0.005798:0.003421:0.011203:0.010434:0.006636:0.010434:0.003421:0.011665:0.004738:0.004738:0.002706:0.011682:0.010434:0.011716:0.004738:0.002709:0.011118:0.011067:0.011203:0.010434:0.011203:0.016044:0.003421:0.011067:0.004738:0.002701:0.011665:0.010399:0.005046:0.011716:0.011118:0.010434:0.004738:0.002704:0.011203:0.005371:0.004738:0.002704:0.011067:0.011682:0.005148:0.003421:0.010434:0.011511:0.004738
for people with cancer: a review. :@0.560572:0.863737:0.848221:0.863737:0.848221:0.849731:0.560572:0.849731:0.005371:0.011203:0.005148:0.006209:0.011665:0.011118:0.011203:0.011665:0.003421:0.011118:0.006209:0.014214:0.003421:0.005798:0.010434:0.006209:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.006200:0.011682:0.006209:0.005077:0.011118:0.009476:0.003421:0.011118:0.014214:0.004738:0.004738
J Oncol :@0.849692:0.863737:0.919871:0.863737:0.919871:0.849731:0.849692:0.849731:0.008244:0.006209:0.014864:0.010434:0.011067:0.011203:0.003421:0.004738
Pract:@0.560572:0.878153:0.604393:0.878153:0.604393:0.864148:0.560572:0.864148:0.010126:0.005148:0.011682:0.011067:0.005798
. 2013;9(4):197-202.:@0.604393:0.878153:0.760094:0.878153:0.760094:0.864148:0.604393:0.864148:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
37.   Parikh  RB,:@0.524225:0.892570:0.644197:0.892570:0.644197:0.878565:0.524225:0.878565:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010126:0.011682:0.005148:0.003421:0.008586:0.010434:0.004738:0.004551:0.010382:0.009818:0.004738
  et  al. :@0.644197:0.892570:0.704279:0.892570:0.704279:0.878565:0.644197:0.878565:0.004738:0.004557:0.011118:0.005798:0.004738:0.004555:0.011682:0.003421:0.004738:0.004738
Early specialty palliative :@0.708846:0.892570:0.919863:0.892570:0.919863:0.878565:0.708846:0.878565:0.009168:0.011682:0.005148:0.003421:0.009168:0.009305:0.006636:0.011665:0.011118:0.011067:0.003421:0.011682:0.003421:0.005798:0.009168:0.009305:0.011665:0.011682:0.003421:0.003421:0.003421:0.011682:0.005798:0.003421:0.009476:0.011118:0.004738
care – translating data in oncology  into :@0.560572:0.906987:0.919900:0.906987:0.919900:0.892982:0.560572:0.892982:0.011067:0.011682:0.005078:0.011118:0.009390:0.008552:0.009390:0.005798:0.005148:0.011682:0.010434:0.006636:0.003421:0.011682:0.005798:0.003421:0.010434:0.011511:0.009390:0.011716:0.011682:0.005798:0.011682:0.009390:0.003421:0.010434:0.009390:0.011203:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.004738:0.004637:0.003421:0.010434:0.005798:0.011203:0.004738
practice:@0.560572:0.921404:0.631538:0.921404:0.631538:0.907399:0.560572:0.907399:0.011665:0.005148:0.011682:0.011067:0.005798:0.003421:0.011067:0.011118
. N Engl J Med:@0.631538:0.921404:0.753584:0.921404:0.753584:0.907399:0.631538:0.907399:0.004738:0.005833:0.012657:0.005822:0.009168:0.010434:0.011511:0.003421:0.005833:0.008244:0.005833:0.015719:0.011118:0.011716
. 2013;369(24):2347-:@0.753584:0.921404:0.915132:0.921404:0.915132:0.907399:0.753584:0.907399:0.004738:0.005824:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009498:0.006312:0.009476:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679
51:@0.560572:0.935821:0.579524:0.935821:0.579524:0.921815:0.560572:0.921815:0.009476:0.009476